image credit: Pexels

Is the FDA Getting Tougher on Drug Applications?

March 26, 2021

Via: BioSpace

It’s already been reported that the U.S. Food and Drug Administration (FDA) is running an industry-wide evaluation of its accelerated approvals. These approvals were typically granted for drugs with a high unmet need and require the companies to conduct post-marketing clinical trials to determine if, in fact, the drugs are as effective as they appeared to be in earlier trials.

Now there appears to be some evidence that the agency is cracking down in general, although there’s debate among analysts about what exactly is going on.

Read More on BioSpace